METASTATIC MALIGNANT SOLID NEOPLASM
Clinical trials for METASTATIC MALIGNANT SOLID NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MALIGNANT SOLID NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC MALIGNANT SOLID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Brain cancer study halted: new radiation methods tested for recurrent tumors
Disease control TerminatedThis study looked at two ways to treat cancer that has spread to the brain and returned after initial radiation. One method used focused radiation only on the new tumors, while the other used whole-brain radiation while trying to protect memory areas and adding a medication to re…
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Experimental cancer combo trial halted early
Disease control TerminatedThis study tested a combination of two immunotherapy drugs (BMS-986218 and nivolumab) plus precise radiation for people with advanced solid tumors that had spread. The goal was to see if this approach could help control the cancer and check for side effects. Only 13 people took p…
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Immunotherapy duo shows promise for HIV cancer patients
Disease control TerminatedThis early-stage study tested two immunotherapy drugs, ipilimumab and nivolumab, in 79 people with HIV who also had advanced solid tumors or Hodgkin lymphoma. The goal was to find the safest dose and see if the combination could shrink tumors. The trial was stopped early, but res…
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Cancer brain metastasis drug combo trial halted early
Disease control TerminatedThis study tested two drugs, bintrafusp alfa and pimasertib, in people whose cancer had spread to the brain. The goal was to find the best dose and see if the combination could slow or stop tumor growth. The trial was stopped early after enrolling only 8 participants, so no clear…
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC